140 related articles for article (PubMed ID: 14695763)
21. Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
Okada H; Attanucci J; Tahara H; Pollack IF; Bozik ME; Chambers WH; Lotze MT
Cancer Gene Ther; 2000 Mar; 7(3):486-94. PubMed ID: 10766355
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus thymidine kinase enzymatic assay in transient transfection experiments using thymidine kinase-deficient cells.
Jonsson JJ; McIvor RS
Anal Biochem; 1991 Dec; 199(2):232-7. PubMed ID: 1667455
[TBL] [Abstract][Full Text] [Related]
23. Thymidine kinase deletion mutants of herpes simplex virus type 1.
Sanders PG; Wilkie NM; Davison AJ
J Gen Virol; 1982 Dec; 63(2):277-95. PubMed ID: 6296278
[TBL] [Abstract][Full Text] [Related]
24. [Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell].
Liang Z; Kuang J; Lin Z
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):467-70. PubMed ID: 9639739
[TBL] [Abstract][Full Text] [Related]
25. [Construction of pGL3-hTERT-tk recombinant plasmid and effect of PEG-PEI/Fe(3)0(4) Nano-magnetic fluid-tk/GCV on proliferation of gastric cancer cells BGC823 in vitro].
Buduwaili WS; Li L; Zhang BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):727-31. PubMed ID: 22851080
[TBL] [Abstract][Full Text] [Related]
26. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
27. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
28. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
29. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K
Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
31. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
[TBL] [Abstract][Full Text] [Related]
32. Synthetic radiation-inducible promoters mediated HSV-TK/GCV gene therapy in the treatment of oral squamous cell carcinoma.
Yu DS; Zhao W; Huang HZ; Hu XW; Liu XQ; Tang HK
Oral Dis; 2010 Jul; 16(5):445-52. PubMed ID: 20412454
[TBL] [Abstract][Full Text] [Related]
33. Expression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells.
Wang Y; Xu HX; Lu MD; Tang Q
World J Gastroenterol; 2008 Jan; 14(2):224-30. PubMed ID: 18186559
[TBL] [Abstract][Full Text] [Related]
34. Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1.
Wei CM; Gibson M; Spear PG; Scolnick EM
J Virol; 1981 Sep; 39(3):935-44. PubMed ID: 6270359
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line.
Wang Y; Mo L; Wei W; Shi X
Int J Nanomedicine; 2013; 8():3805-16. PubMed ID: 24124368
[TBL] [Abstract][Full Text] [Related]
36. Suppression of murine melanoma growth by a vaccine of attenuated Salmonella carrying heat shock protein 70 and Herpes simplex virus-thymidine kinase genes.
Zeng S; Zhang J; Zhang J; Liu Q; Wang S; Wu S; Peng X; Shao J; Huang W
Oncol Rep; 2012 Mar; 27(3):798-806. PubMed ID: 22089382
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
Yu B; Zhang Y; Zhan Y; Zha X; Wu Y; Zhang X; Dong Q; Kong W; Yu X
Oncol Rep; 2011 Jul; 26(1):255-64. PubMed ID: 21573500
[TBL] [Abstract][Full Text] [Related]
38. Structures of replacement vectors for efficient gene targeting.
Horie K; Nishiguchi S; Maeda S; Shimada K
J Biochem; 1994 Mar; 115(3):477-85. PubMed ID: 8056760
[TBL] [Abstract][Full Text] [Related]
39. Application of the mini-Mu-phage for target-sequence-specific insertional mutagenesis of the herpes simplex virus genome.
Jenkins FJ; Casadaban MJ; Roizman B
Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4773-7. PubMed ID: 2991892
[TBL] [Abstract][Full Text] [Related]
40. Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site.
Sugimoto Y; Aksentijevich I; Gottesman MM; Pastan I
Biotechnology (N Y); 1994 Jul; 12(7):694-8. PubMed ID: 7764914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
